Table 3.
Effect of low and high doses of metal nanocomposite on total protein, albumin (A), globulin (G), A/G ratio, alanine aminotransferase (ALT) and gamma glutamyl transferase (GGT) (Mean ± SE) n = 5
| G | Total protein (g/dl) | Albumin (g/dl) | Globulin (g/dl) | A/G ratio | ALT (u/l) | GGT (u/l) | |
|---|---|---|---|---|---|---|---|
| After treatment | 1 | 3.42 ± 0.10c | 1.64 ± 0.05b | 1.78 ± 0.04c | 0.92 ± 0.03a | 4.00 ± 0.11a | 12.56 ± 0.44a |
| 2 | 2.43 ± 0.07a | 1.33 ± 0.02a | 1.1 ± 0.02a | 1.21 ± 0.05c | 5.83 ± 0.06b | 14.00 ± 0.64b | |
| 3 | 3.34 ± 0.11c | 1.45 ± 0.03ab | 1.89 ± 0.02c | 0.77 ± 0.02a | 5.33 ± 0.13b | 13.60 ± 0.32b | |
| 4 | 3.57 ± 0.13c | 1.46 ± 0.04ab | 2.11 ± 0.05c | 0.69 ± 0.02a | 6.53 ± 0.12c | 14.65 ± 0.27c | |
| 5 | 2.85 ± 0.09b | 1.48 ± 0.03ab | 1.37 ± 0.03b | 1.08 ± 0.03b | 6.80 ± 0.17c | 14.53 ± 0.45c | |
| 6 | 2.96 ± 0.06b | 1.52 ± 0.05b | 1.44 ± 0.03b | 1.06 ± 0.03b | 7.30 ± 0.30d | 15.32 ± 0.68d | |
| At the end of the experiment | 1 | 3.13 ± 0.14b | 1.70 ± 0.07b | 1.43 ± 0.04b | 1.19 ± 0.05a | 4.43 ± 0.09a | 14.33 ± 0.41a |
| 2 | 1.97 ± 0.08a | 1.23 ± 0.04a | 0.74 ± 0.02a | 1.66 ± 0.05b | 6.02 ± 0.14c | 17.66 ± 0.57c | |
| 3 | 2.98 ± 0.12b | 1.47 ± 0.05ab | 1.51 ± 0.06c | 0.97 ± 0.01a | 4.89 ± 0.07a | 13.00 ± 0.34a | |
| 4 | 3.10 ± 0.08b | 1.56 ± 0.04b | 1.54 ± 0.05c | 1.01 ± 0.03a | 5.45 ± 0.11b | 15.32 ± 0.46b | |
| 5 | 2.83 ± 0.07b | 1.45 ± 0.06ab | 1.38 ± 0.05b | 1.05 ± 0.02a | 5.62 ± 0.11b | 15.00 ± 0.52b | |
| 6 | 2.98 ± 0.07b | 1.61 ± 0.07b | 1.37 ± 0.04b | 1.18 ± 0.04a | 5.87 ± 0.10c | 17.78 ± 0.63c |
The various letters in the same column of the same period indicate statistically significant differences when (P < 0.05)
G1 = OTA free control, G2 = OTA fed positive control, G3 = OTA free (low dose), G4 = OTA free (high dose), G5 = OTA treated (low dose), G6 = OTA treated (high dose)